CSEI

Receivable Acquisition & Management Corp.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/13/2016
Contact Info
  • 60 E. 42nd Street
  • 46th Floor
  • New York, NY 10165

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0000733337
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 6153 - Short-term business credit
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Thomas Telegades CEO, Acting CFO
Peter Fazio COO
Wallace Baker Chief Admin. Officer
Company Directors
James A. Valentino Chairman
Wallace Baker
Peter Fazio
Thomas Telegades
Company Notes
  • Formerly=Feminique Corp. until 5-04
  • Note=8-00 company filed petition under Chapter XI of the Federal Bankruptcy Code. 7-28-03 U.S. Bankruptcy Court Eastern District of New York confirmed & approved the company's Plan of Reorganization: company to issue 23,344,085 Com shs to creditors & current shareholders to retain their share ownership
  • Formerly=Biopharmaceutics, Inc. until 7-99
  • Formerly=Integrated Generics, Inc. to 6-88
Service Providers
Accounting/Auditing Firm
PKF O'Connor Davies, LLP
29 Broadway
New York, NY, 10006
United States

Legal Counsel
Davidoff Hutcher & Citron LLP
605 Third Ave.
New York, NY, 10158
United States

Investor Relations Firm
Not Available
CSEI Security Details
Share Structure
Market Value1 $3,512,940 a/o Dec 02, 2016
Authorized Shares 325,000,000 a/o Sep 30, 2016
Outstanding Shares 200,739,432 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 15,716,863 a/o Jun 30, 2016
Par Value 0.001
Shareholders
Shareholders of Record 253 a/o Mar 22, 2016
Short Selling Data
Short Interest 0 (-100%)
Jan 15, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security